Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Haga

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
NPJ Vaccines|March 19, 2023
Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunityTapas Patra, Keith Meyer, Yuki Haga, et al.
Biochemical and Biophysical Research Communications|April 2, 2017
Interferon induces interleukin 8 and bone marrow stromal cell antigen 2 expression, inhibiting the production of hepatitis B virus surface antigen from human hepatocytesYuki Haga, Tatsuo Kanda, Shingo Nakamoto, et al.
Environmental Pollution (Barking, Essex : 1987)|July 28, 2020
Pesticide treatment reduces hydrophobic pollutant contamination in Cucurbita pepo through competitive binding to major latex-like proteinsKentaro Fujita, Yasumitsu Kondoh, Kaori Honda, et al.
Journal of Virology|September 5, 2025
Hepatitis C virus modified <sub>S</sub>E2<sub>F442NYT</sub>-mRNA-LNP candidate vaccine promotes helper CXCR5<sup>+</sup>T cellsYuki Haga, Preedia Babu E, Marzena Swiderska-Syn, et al.
Journal of Virology|December 12, 2023
Hepatitis C virus modified sE2<sub>F442NYT</sub> as an antigen in candidate vaccine facilitates human immune cell activationYuki Haga, Keith Meyer, Molly M H Sung, et al.
Plos One|December 5, 2015
MicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate CellsMasato Nakamura, Tatsuo Kanda, Reina Sasaki, et al.
Diseases (Basel, Switzerland)|September 26, 2017
HBV Core Protein Enhances Cytokine ProductionTatsuo Kanda, Shuang Wu, Reina Sasaki, et al.
Plos One|March 22, 2017
Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell linesYuki Haga, Tatsuo Kanda, Masato Nakamura, et al.
Plos One|January 6, 2016
Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate CellsReina Sasaki, Tatsuo Kanda, Masato Nakamura, et al.
Journal of Clinical and Translational Hepatology|December 2, 2015
Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A VirusTatsuo Kanda, Shingo Nakamoto, Shuang Wu, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
NPJ Vaccines|March 19, 2023
Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunityTapas Patra, Keith Meyer, Yuki Haga, et al.
Biochemical and Biophysical Research Communications|April 2, 2017
Interferon induces interleukin 8 and bone marrow stromal cell antigen 2 expression, inhibiting the production of hepatitis B virus surface antigen from human hepatocytesYuki Haga, Tatsuo Kanda, Shingo Nakamoto, et al.
Environmental Pollution (Barking, Essex : 1987)|July 28, 2020
Pesticide treatment reduces hydrophobic pollutant contamination in Cucurbita pepo through competitive binding to major latex-like proteinsKentaro Fujita, Yasumitsu Kondoh, Kaori Honda, et al.
Journal of Virology|September 5, 2025
Hepatitis C virus modified <sub>S</sub>E2<sub>F442NYT</sub>-mRNA-LNP candidate vaccine promotes helper CXCR5<sup>+</sup>T cellsYuki Haga, Preedia Babu E, Marzena Swiderska-Syn, et al.
Journal of Virology|December 12, 2023
Hepatitis C virus modified sE2<sub>F442NYT</sub> as an antigen in candidate vaccine facilitates human immune cell activationYuki Haga, Keith Meyer, Molly M H Sung, et al.
Plos One|December 5, 2015
MicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate CellsMasato Nakamura, Tatsuo Kanda, Reina Sasaki, et al.
Diseases (Basel, Switzerland)|September 26, 2017
HBV Core Protein Enhances Cytokine ProductionTatsuo Kanda, Shuang Wu, Reina Sasaki, et al.
Plos One|March 22, 2017
Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell linesYuki Haga, Tatsuo Kanda, Masato Nakamura, et al.
Plos One|January 6, 2016
Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate CellsReina Sasaki, Tatsuo Kanda, Masato Nakamura, et al.
Journal of Clinical and Translational Hepatology|December 2, 2015
Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A VirusTatsuo Kanda, Shingo Nakamoto, Shuang Wu, et al.
Pageof 8